Page 77 - Linical Workflow Optimization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linical workflow optimization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linical Workflow Optimization Today - Breaking & Trending Today

BD India partners with Sehgal Path Lab to launch third Clinical CoE in Flow Cytometry for Clinical Research

New Delhi, May 11: BD Life Sciences-Biosciences, a segment of BD (Becton, Dickinson, and Company), in collaboration with Sehgal Path Lab recently launched its Center of Excellence (CoE) in Flow Cytometry for clinical research in Mumbai. Aimed to serve as the National Reference Center for clinical diagnostics applications, this is the third clinical CoE in Flow Cytometry by BD in India. Hematologists, physicians, and lab specialists from across India can come together at this CoE to deliberate and discuss standardization and best practices in clinical Flow Cytometry. ....

West Bengal , New Delhi , Puneet Talwar , Kunal Sehgal , Vellore Co , Hinduja Co , University Co , Rajnath Singh At National Technology Day , Bd Life Sciences , Sehgal Path Lab Pvt , Centers Of Excellence , National Reference Center , Clinical Research , Sehgal Path Lab , Iiser Bd Centre Of Excellence Co , Clinical Coe , Flow Cytometry , Atul Grover , Managing Director , South Asia , Path Lab , Minimal Residual Disease , Clinical Flow , Calcutta University Coe , Advanced Flow Cytometry , Clinical Flow Cytometry ,

Qilu Pharmaceutical Co., Ltd.: Results of Phase I Clinical Study of Qilu Pharma's PD-1/CTLA-4 Bifunctional Antibody Iparomlimab/Tuvonralimab Published Online in Journal of Hematology & Oncology

JINAN, China, May 12, 2023 /PRNewswire/ On May 8, 2023, Journal of Hematology & Oncology (JHO, 2022 impact factor of 23.168) published the results of the Phase I clinical study of Qilu Pharma's ....

Li Zhang , Qilu Pharma , Sun Yat Sen University Cancer Center , Sun Yat Sen University Cancer , Gefallene Big Techs ,